Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including T2D and obesity. Fractyl Health is based in Lexington, MA.
| Revenue (Most Recent Fiscal Year) | $0.09M |
| Net Income (Most Recent Fiscal Year) | $-68.69M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 2829.30 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -4073233.50% |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -2896.77% |
| Return on Assets (Trailing 12 Months) | -105.72% |
| Current Ratio (Most Recent Fiscal Quarter) | 4.27 |
| Quick Ratio (Most Recent Fiscal Quarter) | 4.27 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 4.61 |
| Inventory Turnover (Trailing 12 Months) | 0.00 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.59 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.35 |
| Earnings per Share (Most Recent Fiscal Year) | $-2.03 |
| Diluted Earnings per Share (Trailing 12 Months) | $-2.29 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 137.04M |
| Free Float | 101.28M |
| Market Capitalization | $263.12M |
| Average Volume (Last 20 Days) | 2.98M |
| Beta (Past 60 Months) | 1.96 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 26.10% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |